GLUE Competitors & Alternatives
Compare Monte Rosa Therapeutics Inc with similar stocks in the same industry
Biotechnology
GLUE
Main Stock$14.30
Tradestie Score
55
Market Cap
$463.20M
Revenue Growth
-0.6%
Analyst Upside
+99.3%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$48.24
|
$1.32B | - | 38 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.70
|
$1.29B | - | 41 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$32.29
|
$1.29B | - | 51 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.89
|
$1.29B | - | 63 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.67
|
$1.28B | - | 30 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.93
|
$1.27B | - | 40 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.38
|
$1.22B | - | 50 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$7.20
|
$1.18B | - | 41 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$59.82
|
$1.17B | - | 46 | Compare |
More GLUE Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry